Association between telomere length with alcohol use disorder and internalizing/externalizing comorbidities in a Brazilian male sample

Helena Ferreira Moura,Jaqueline Bohrer Schuch,Felipe Ornell,Cibele Edom Bandeira,Raffael Massuda,Claiton Henrique Dotto Bau,Eugenio Horácio Grevet,Felix H.P. Kessler,Lisia von Diemen
DOI: https://doi.org/10.1016/j.alcohol.2024.04.004
IF: 2.558
2024-04-17
Alcohol
Abstract:Background Shortening telomere length (TL) is an important ageing marker associated with substance use disorder (SUD). However, the influence of psychiatric and clinical comorbidities and alcohol-related outcomes has not been much explored in the context of TL in individuals with alcohol use disorder (AUD) and may be a source of heterogeneity in AUD studies. Therefore, our aim was to investigate the influence of AUD, alcohol-related outcomes, and common psychiatric comorbidities on TL in men with AUD and healthy controls (HC). Methods Men with AUD (n=108, mean age=52.4, SD=8.6) were recruited in a detoxification unit, and HC (n=80, mean age=50.04, SD=9.1) from the blood bank, both located in Brazil. HC had no current or lifetime diagnosis of any substance use disorder. Psychiatric comorbidities were assessed using SCID-I. TL ratio was measured in triplicates using quantitative multiplex PCR. Results Telomere length did not differ between individuals with AUD and HC (p=0.073) or was associated with AUD-related outcomes, trauma, or clinical comorbidities. Individuals with externalizing disorders had longer TL when comparing with those with internalizing disorders (p=0.018) or without comorbidity (p=0.018). Conclusion Our findings indicate that TL was influenced by the presence of psychiatric comorbidity rather than case or control status. These results were adjusted for potential confounders, such as age.
pharmacology & pharmacy,toxicology,substance abuse
What problem does this paper attempt to address?